Digital Therapeutics Market Volume, Growth and Strategic Review 2030

Digital Therapeutics Market Poised for Robust Growth, forecasted to Expand at 20% CAGR from 2024-30

MarkNtel Advisors has released its latest report highlighting strong growth in The Global Digital Therapeutics Market is estimated to grow at a CAGR of around 20% during the forecast period, i.e., 2024-30. 

Report Coverage: Size, Scope and Share

This report offers a comprehensive analysis of the Digital Therapeutics Market, providing valuable insights across historical trends, current dynamics, and future forecasts.

• Base Year: 2023
• Forecast Years: 2024-30
• Historical Years: 2019-22

How big is Digital Therapeutics Market?

The market growth has been primarily attributed to the high healthcare costs, which have increased the adoption of digital therapeutic solutions that offer remote & scalable interventions to prevent or manage conditions, thus reducing the need for expensive in-person care. Further, there has been widespread availability of smartphones across the world and this has successfully propelled the adoption of digital therapeutics across nations. For instance, as per the Global System for Mobile Communications Association (GSMA), in 2023, about 4.3 billion people, which is 54% of the global population, own a smartphone. With that, the commercialization and clinical application of digital therapeutics (DTx) has significantly increased, accelerating the overall Digital Therapeutics Market.

What factor drive Digital Therapeutics market growth during 2024-30?

Increasing Prevalence of Preventable Chronic Diseases to Infuse the Market Growth – There has been a significant prevalence of preventable chronic diseases, such as diabetes, cardiovascular diseases (CVDs), etc., across the globe. For instance, as per the International Diabetes Federation (IDF), worldwide, approximately 537 million adults aged between 20-79 years were living with diabetes in 2021. Further, the total number of patients with diabetes is projected to rise to 643 million by 2030 & 783 million by 2045.

Empower Your Business Decisions – Download a Free Sample Now  -  https://www.marknteladvisors.com/query/request-sample/digital-therapeutics-market.html

How Digital Therapeutics Market Are Segmented?

The Digital Therapeutics is categorized into notable segments, which help in understanding the structure, dynamics, and opportunities within the market. These segments are typically based on:

By Product

• Software
• Hardware

By Application

• Preventive
  • Pre-Diabetes
  • Obesity
  • Smoking Cessation
  • Others (Hypertension, Sleep Hygiene, etc.)
• Treatment/Care
  • Cardiovascular Diseases (CVDs)
  • Central Nervous System Diseases
  • Diabetes
  • Musculoskeletal Diseases
  • Others (Respiratory Diseases, Drug Substance Abuse, etc.)

By Business Model

• Business-to-Consumer (B2C)
• Business-to-Business (B2B)

By Region

• North America
• South America
• Europe
• The Middle East & Africa
• Asia-Pacific

Click here to access the full Digital Therapeutics Market report and take advantage of our special pricing offer-   https://www.marknteladvisors.com/research-library/digital-therapeutics-market.html

Who is the leader in the Digital Therapeutics market?

 By MarkNtel Advisors the Top Digital Therapeutics manufacturer/companies globally are Omada Health Inc., Google (Fitbit Health Solutions), 2Morrow® Inc., Teladoc Health. Inc. (Livongo), ResMed (Propeller Health), Aptar (Voluntis, Inc.), Welldoc, Inc., Canary Health, Noom, Inc., Biofourmis, Click Therapeutics, Better Therapeutics, Cognoa, CogniFit Inc., Virta Health, Others as key players shaping the market landscape.

What are latest advancement in the Digital Therapeutics sector?

• 2024: Otsuka Pharmaceutical, Co. Ltd. and Click Therapeutics, Inc., announced that the US Food and Drug Administration (FDA) has cleared Rejoyn™ (developed as CT-152), the first prescription digital therapeutic authorized for the treatment of major depressive disorder (MDD).
• 2023: 2Morrow® Inc., was awarded USD 1.9 Million NIH Grant to Develop a Digital Therapeutic for Patients with Chronic Pain.

Why This Research Report:

• In-depth Market Analysis: Understand trends and dynamics shaping growth.
• Segmented Insights: Target specific segments for focused strategies.
• Regional Performance: Assess market opportunities by geographic area.
• Emerging Technologies: Discover advancements like AI integration.
• Risk Identification: Pinpoint challenges to inform strategic planning.
• Future Forecasts: Prepare for market changes with actionable projections.

Need tailored data? We offer customized forecasts by region, product segmentation, and competitive intelligence upon request — now with an exclusive special pricing offer – Customized Link

Other Report:

https://reportjournalamit.blogspot.com/2025/08/mass-spectrometry-market-forecast.html

Our Trusted Experts Are Here to Help:

At MarkNtel Advisors, we are committed to delivering data-driven insights and strategic intelligence that empower your business decisions. Whether you have a question, need customized research, or want to explore partnership opportunities, our team is here to support you every step of the way.

Reach Us:

MarkNtel Advisors

Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India

Contact No: +91 8719999009

Email: sales@marknteladvisors.com

Visit our Website: https://www.marknteladvisors.com

We’re always open to sharing insights, exploring ideas. Follow us to stay updated on the latest news and industry trends.